Predicting adverse outcomes after complex cancer surgery
- PMID: 20585873
- PMCID: PMC2924501
- DOI: 10.1245/s10434-010-1179-9
Predicting adverse outcomes after complex cancer surgery
Comment on
-
Assessment of ACS NSQIP's predictive ability for adverse events after major cancer surgery.Ann Surg Oncol. 2010 Sep;17(9):2274-82. doi: 10.1245/s10434-010-1176-z. Epub 2010 Jun 29. Ann Surg Oncol. 2010. PMID: 20585875
References
-
- Borja-Cacho D, Parsons HM, Habermann EB, Rothenberger D, Henderson WG, Al-Rafaie WB. Assessment of ACS NSQIP’s predictive ability for adverse events after major cancer surgery. Ann Surg Oncol. 2010. doi:10.1245/s10434-010-1176-z. - PubMed
-
- Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371(9617):1007–1016. doi: 10.1016/S0140-6736(08)60455-9. - DOI - PMC - PubMed
